Offices of Biotechnology and Business Development

Presentations, News & Publications

When a Drug Becomes a Child’s Last Hope for T-Cell Leukemia

Albert Einstein College of Medicine scientist Vern Schramm never imagined that his lifelong quest to decode enzyme inhibitors would intersect with the life of two-year-old Katie, who had an incurable form of T-cell acute lymphoblastic leukemia (T-cell ALL). Dr. Schramm, Katie Lambertson, now a teenager, and her parents Jeff and Linda, share their stories about the road to drug development and the experimental drug treatment that would change the course of their lives.

Click here to log in